NCT05017688View on ClinicalTrials.gov

Prospective Interventional Study Exploring the Microbiota Recolonization in SR-GvHD Patients Receiving MaaT013

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 6, 2021

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2024

Conditions
Intestinal GVHDSteroid Refractory GVHD
Interventions
PROCEDURE

Blood and stool sample collection

Collection of blood samples (55 mL) Collection of fecal samples (10g)

Trial Locations (9)

14033

RECRUITING

Chu de Caen, Caen

31059

RECRUITING

Institut Universitaire Du Cancer de Toulouse - Oncopole, Toulouse

35033

ACTIVE_NOT_RECRUITING

Chu de Rennes - Hopital Pontchaillou, Rennes

38043

RECRUITING

Chu Grenoble, Grenoble

69310

ACTIVE_NOT_RECRUITING

Chu Lyon Sud, Pierre-Bénite

75012

RECRUITING

Aphp - Hopital Saint Antoine, Paris

80054

RECRUITING

Chu Amiens Picardie Site Sud, Amiens

86021

RECRUITING

Chu La Miletrie, Poitiers

06200

RECRUITING

Chu de Nice - L'Archet 1, Nice

Sponsors

Lead Sponsor

MaaT Pharma
All Listed Sponsors
lead

MaaT Pharma

INDUSTRY